- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Therapies for Glioblastoma
Authors
Keywords
-
Journal
Current Neurology and Neuroscience Reports
Volume 20, Issue 7, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-22
DOI
10.1007/s11910-020-01042-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?
- (2020) Joseph D. Wilson et al. Frontiers in Oncology
- Controlling Cytokine Release Syndrome to Harness the Full Potential of CAR-Based Cellular Therapy
- (2020) Monica S. Thakar et al. Frontiers in Oncology
- A step towards international prospective trials in carbon ion radiotherapy: investigation of factors influencing dose distribution in the facilities in operation based on a case of skull base chordoma
- (2019) G. Vogin et al. Radiation Oncology
- Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
- (2019) Timothy F. Cloughesy et al. NATURE MEDICINE
- Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality
- (2019) Jo Ishizawa et al. CANCER CELL
- A randomized phase II trial of veliparib (V), radiotherapy (RT) and temozolomide (TMZ) in patients (pts) with unmethylated MGMT (uMGMT) glioblastoma (GBM).
- (2019) Mustafa Khasraw et al. JOURNAL OF CLINICAL ONCOLOGY
- SurVaxM with standard therapy in newly diagnosed glioblastoma: Phase II trial update.
- (2019) Manmeet Singh Ahluwalia et al. JOURNAL OF CLINICAL ONCOLOGY
- Carbon ion reirradiaton for patients with malignant gliomas: Toxicity and first results of the prospective dose-escalation phase I/II CINDERELLA trial.
- (2019) Stephanie E Combs et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II study of abemaciclib in patients (pts) with brain metastases (BM) secondary to HR+, HER2- metastatic breast cancer (MBC).
- (2019) Carey K. Anders et al. JOURNAL OF CLINICAL ONCOLOGY
- Interim results of a phase I/IIa trial of a therapeutic CMV vaccine against recurrent glioblastoma (GBM).
- (2019) Andrew B. Lassman et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species
- (2019) Pierre Montay-Gruel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Phase 0 Trial of Ribociclib in Recurrent Glioblastoma Patients Incorporating a Tumor Pharmacodynamic- and Pharmacokinetic-Guided Expansion Cohort
- (2019) An-Chi Tien et al. CLINICAL CANCER RESEARCH
- A Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With Glioblastoma
- (2019) Patrick Y. Wen et al. CLINICAL CANCER RESEARCH
- CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity
- (2019) Bryan D. Choi et al. NATURE BIOTECHNOLOGY
- Mechanisms of immunotherapy resistance: lessons from glioblastoma
- (2019) Christopher M. Jackson et al. NATURE IMMUNOLOGY
- Reduced cognitive deficits after FLASH irradiation of whole mouse brain are associated with less hippocampal dendritic spine loss and neuroinflammation
- (2019) Danielle A. Simmons et al. RADIOTHERAPY AND ONCOLOGY
- Treatment of a first patient with FLASH-radiotherapy
- (2019) Jean Bourhis et al. RADIOTHERAPY AND ONCOLOGY
- Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
- (2019) E. Antonio Chiocca et al. Science Translational Medicine
- TRK inhibitors in TRK fusion-positive cancers
- (2019) A Drilon ANNALS OF ONCOLOGY
- Molecular Evolution of IDH Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study
- (2019) Kaspar Draaisma et al. JOURNAL OF CLINICAL ONCOLOGY
- Carbon ion radiotherapy in the treatment of gliomas: a review
- (2019) Timothy D. Malouff et al. JOURNAL OF NEURO-ONCOLOGY
- Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201
- (2019) Andrew S. Chi et al. JOURNAL OF NEURO-ONCOLOGY
- Longitudinal molecular trajectories of diffuse glioma in adults
- (2019) Floris P. Barthel et al. NATURE
- ACTR-39. PAMIPARIB IN COMBINATION WITH RADIATION THERAPY (RT) AND/OR TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED OR RECURRENT/REFRACTORY (R/R) GLIOBLASTOMA (GBM); PHASE 1B/2 STUDY UPDATE
- (2019) Anna Piotrowski et al. NEURO-ONCOLOGY
- ACTR-30. UPDATED EFFICACY AND SAFETY OF DABRAFENIB PLUS TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E–MUTATED HIGH-GRADE GLIOMA (HGG) AND LOW-GRADE GLIOMA (LGG)
- (2019) Patrick Wen et al. NEURO-ONCOLOGY
- INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFRamplified glioblastoma
- (2019) Martin van den Bent et al. NEURO-ONCOLOGY
- Ultra high dose rate (35 Gy/sec) radiation does not spare the normal tissue in cardiac and splenic models of lymphopenia and gastrointestinal syndrome
- (2019) Bhanu Prasad Venkatesulu et al. Scientific Reports
- Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study
- (2019) Andrew J Brenner et al. NEURO-ONCOLOGY
- A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)
- (2019) Timothy F Cloughesy et al. NEURO-ONCOLOGY
- First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy
- (2019) Pamela Munster et al. Cancer Management and Research
- Quo Vadis—Do Immunotherapies Have a Role in Glioblastoma?
- (2018) Sylvia C. Kurz et al. Current Treatment Options in Neurology
- First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
- (2018) Linda M. Liau et al. Journal of Translational Medicine
- Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug Conjugate
- (2018) Andrew C. Phillips et al. MOLECULAR CANCER THERAPEUTICS
- Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC
- (2018) Timothy F Cloughesy et al. NEURO-ONCOLOGY
- OUP accepted manuscript
- (2018) NEUROSURGERY
- Recurrent Glioblastoma Treated with Recombinant Poliovirus
- (2018) Annick Desjardins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of Brain Metastases in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer
- (2018) William J. Kelly et al. Frontiers in Oncology
- Phase I clinical trials evaluating olaparib in combination with radiotherapy (RT) and/or temozolomide (TMZ) in glioblastoma patients: Results of OPARATIC and PARADIGM phase I and early results of PARADIGM-2.
- (2018) Anthony J. Chalmers et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 2 trial of SL-701 in relapsed/refractory (r/r) glioblastoma (GBM): Correlation of immune response with longer-term survival.
- (2018) David M. Peereboom et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma
- (2018) Jennie W. Taylor et al. JOURNAL OF NEURO-ONCOLOGY
- P01.084 Re-irradiation in recurrent glioblastoma: proton therapy with or without chemotherapy
- (2018) D Amelio et al. NEURO-ONCOLOGY
- BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET Study
- (2018) Thomas Kaley et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of the DNA-dependent protein kinase catalytic subunit is associated with the radiosensitivity of human thyroid cancer cell lines
- (2018) Makoto Ihara et al. JOURNAL OF RADIATION RESEARCH
- Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial
- (2018) Giuseppe Lombardi et al. LANCET ONCOLOGY
- Actively personalized vaccination trial for newly diagnosed glioblastoma
- (2018) Norbert Hilf et al. NATURE
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- The role of CMV in glioblastoma and implications for immunotherapeutic strategies
- (2018) Maryam Rahman et al. OncoImmunology
- CNS side effects of immune checkpoint inhibitors: preclinical models, genetics and multimodality therapy
- (2017) Gwendolyn J McGinnis et al. Immunotherapy
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- CDK4/6 inhibition triggers anti-tumour immunity
- (2017) Shom Goel et al. NATURE
- Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143
- (2017) Antonio Omuro et al. NEURO-ONCOLOGY
- OS10.3 Randomized Phase 3 Study Evaluating the Efficacy and Safety of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: CheckMate 143
- (2017) D. A. Reardon et al. NEURO-ONCOLOGY
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma
- (2017) Isabel Arrillaga-Romany et al. Oncotarget
- HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma
- (2017) Nabil Ahmed et al. JAMA Oncology
- Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma
- (2016) Robert A. Fenstermaker et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A novel small molecule inhibitor of the DNA repair protein Ku70/80
- (2016) Eric Weterings et al. DNA REPAIR
- Radiosensitivity of Patient-Derived Glioma Stem Cell 3-Dimensional Cultures to Photon, Proton, and Carbon Irradiation
- (2016) Sara Chiblak et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
- (2016) Eric Bouffet et al. JOURNAL OF CLINICAL ONCOLOGY
- Proton beam therapy with concurrent chemotherapy for glioblastoma multiforme: comparison of nimustine hydrochloride and temozolomide
- (2016) Masashi Mizumoto et al. JOURNAL OF NEURO-ONCOLOGY
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selective Inhibition of Parallel DNA Damage Response Pathways Optimizes Radiosensitization of Glioblastoma Stem-like Cells
- (2015) S. U. Ahmed et al. CANCER RESEARCH
- Bioactivity and Safety of IL13R 2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
- (2015) C. E. Brown et al. CLINICAL CANCER RESEARCH
- Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
- (2015) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immunosuppressive mechanisms in glioblastoma: Fig. 1.
- (2015) Edjah K. Nduom et al. NEURO-ONCOLOGY
- PO-0799: Normal brain, neural stem cells and glioblastoma responses to FLASH radiotherapy
- (2015) P. Montay - Gruel et al. RADIOTHERAPY AND ONCOLOGY
- Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase
- (2014) Ross Carruthers et al. Molecular Oncology
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice
- (2014) V. Favaudon et al. Science Translational Medicine
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation
- (2013) L. Biddlestone-Thorpe et al. CLINICAL CANCER RESEARCH
- Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma
- (2013) Andrew E. Sloan et al. JOURNAL OF NEUROSURGERY
- Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide
- (2011) Stuart A. Grossman et al. CLINICAL CANCER RESEARCH
- Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies
- (2011) P. C. De Witt Hamer NEURO-ONCOLOGY
- Changes in neuronal activation patterns in response to androgen deprivation therapy: a pilot study
- (2010) Monique M Cherrier et al. BMC CANCER
- Regorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
- (2010) Scott M. Wilhelm et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting DNA-PKcs and ATM with miR-101 Sensitizes Tumors to Radiation
- (2010) Dan Yan et al. PLoS One
- Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma
- (2009) B. Neyns et al. ANNALS OF ONCOLOGY
- Combining drugs and radiotherapy: from the bench to the bedside
- (2009) Kamalakannan Palanichamy et al. CURRENT OPINION IN NEUROLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Replication-Dependent Radiosensitization of Human Glioma Cells by Inhibition of Poly(ADP-Ribose) Polymerase: Mechanisms and Therapeutic Potential
- (2008) Fiona A. Dungey et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started